$PEP

PEPSICO INC

4
13
13

No SEC Form 4 filings for $PEP in the last 30 days.

See all $PEP insider activity →
Low

15 Most Notable Grocery Products Likely Discontinued In 2026 So Far

Food manufacturers are discontinuing products in 2026 due to changing consumer habits and cost-cutting strategies. Coca-Cola is ending Minute Maid frozen juice concentrate, while PepsiCo is reportedly cutting 20% of its snack line, including Cheetos Puffs, Lay's Baked chips, and others. These changes reflect shifts in demand and a focus on healthier, more cost-effective options.

GLP-1 prices are falling but a big change could affect what you pay

Novo Nordisk will cut U.S. list prices for Ozempic and Wegovy by 34% and 50% respectively, starting in 2027. Eli Lilly's new GLP-1 pill, Foundayo, was approved by the FDA. Prices vary by insurance coverage. Some employers, like PepsiCo and Cigna, are ending weight loss drug coverage. New drugs from Lilly, Novo Nordisk, and Amgen are in development.

PEP sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 30 news stories mentioning PEP (PEPSICO INC). Coverage has skewed bearish: 4 bullish, 13 neutral, and 13 bearish.

Recent PEP coverage spans regulation, corporate actions and market movers.

What's driving PEP

AlphAI scores every news story that mentions PEP with an AI model for sentiment and relevance, and aggregates insider trades from PEPSICO INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PEP

Score
$PEPLow

15 Most Notable Grocery Products Likely Discontinued In 2026 So Far

Food manufacturers are discontinuing products in 2026 due to changing consumer habits and cost-cutting strategies. Coca-Cola is ending Minute Maid frozen juice concentrate, while PepsiCo is reportedly cutting 20% of its snack line, including Cheetos Puffs, Lay's Baked chips, and others. These changes reflect shifts in demand and a focus on healthier, more cost-effective options.

$NVOMed

GLP-1 prices are falling but a big change could affect what you pay

Novo Nordisk will cut U.S. list prices for Ozempic and Wegovy by 34% and 50% respectively, starting in 2027. Eli Lilly's new GLP-1 pill, Foundayo, was approved by the FDA. Prices vary by insurance coverage. Some employers, like PepsiCo and Cigna, are ending weight loss drug coverage. New drugs from Lilly, Novo Nordisk, and Amgen are in development.

$KOLow

This stock’s defensive appeal faces a valuation test. Here's where else investors can look

Coca-Cola (KO) is a defensive stock with stable earnings and a strong brand, but its premium valuation and legal risks make it less compelling. PepsiCo (PEP) and Keurig Dr Pepper offer lower valuations and higher dividend yields. KO's Q2 organic sales rose 6%, and it raised full-year guidance. Analysts are mixed on KO's upside, with an average price target of $94.25. PEP is undergoing a turnaround, with a 4.6% dividend yield and a 15x P/E multiple, but faces challenges in North America.

Big Food warns growing scrutiny of ultra-processed foods could hit sales and costs

Conagra, Kraft Heinz, JM Smucker, PepsiCo, and Campbell Soup warn in SEC filings that scrutiny of ultra-processed foods (UPFs) could hurt sales, raise costs, and trigger new regulations. Campbell Soup highlights potential compliance costs and demand impacts. PepsiCo notes reputational risks and state laws may limit sales. Conagra and Kraft Heinz face litigation over UPF health claims.

$PEPMed

PepsiCo shares slip as Bloomberg reports retreat from snack price cuts

PepsiCo shares declined 0.5% after Bloomberg reported the company plans to raise prices on some chips, soda, and dips by a low-to-mid single-digit percentage, reversing earlier price cuts that did not boost sales. The increases, expected by early 2027, will not exceed pre-cut levels. PepsiCo aims to balance inflation with affordability. According to Bloomberg, the reversal highlights challenges in consumer goods.

PepsiCo shutters 60-year-old Maryland plant, laying off 143 workers as weakening soda demand drives nationwide closures

PepsiCo is closing a 60-year-old Maryland plant, laying off 143 workers. The move follows other closures and layoffs in 2025 and 2026, totaling over 1,000 jobs. The company cites weakening soda demand due to inflation and changing consumer tastes. PepsiCo is restructuring to improve productivity and has launched healthier products to adapt to market shifts, according to The Street and the company.

Related tickers